1-5 of 5
Diane R Mould
Close
Sort by
Journal Articles

Population Pharmacokinetics (PPK) and Exposure-Response to Support Body Surface Area (BSA)-Based Dosing of Brentuximab Vedotin in Pediatric Patients with Advanced-Stage Newly-Diagnosed Hodgkin Lymphoma (HL)

Xiaofei Zhou, Diane R Mould, Anna R K Franklin, Lia Gore, Xiang Bai, Neeraj Gupta
Journal: Blood
Blood (2022) 140 (Supplement 1): 3724–3725.
https://doi.org/10.1182/blood-2022-160105
Published: 2022
Journal Articles

Results of PAC203: A Randomized Phase 2 Dose-Finding Study and Determination of the Recommended Dose of Pacritinib

Aaron T. Gerds, MD MS, Michael R. Savona, MD, Bart L. Scott, MD, Moshe Talpaz, MD, Miklos Egyed, Claire N Harrison, Professor, Abdulraheem Yacoub, MD, Alessandro M. Vannucchi, MD, Adam J. Mead, MD PhD, Jennifer O'Sullivan, Sarah A Buckley, MD, Diane R. Mould, PhD, Shanthakumar Tyavanagimatt, PhD, Jennifer A. Smith, PhD, John Mascarenhas, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 667.
https://doi.org/10.1182/blood-2019-129293
Published: 2019
Journal Articles

Elucidating Exposure-Response (Safety and Efficacy) of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Containing Antibody Drug Conjugate, for Recommended Phase 2 Dose Determination in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Owen Anthony O'Connor, MD, Brad S Kahl, MD, Mehdi Hamadani, MD, Paolo Caimi, MD, Erin Reid, MD, Jay Feingold, MD PhD, Karin Havenith, PhD, Shui He, PhD, Diane R Mould, PhD, Immanuel Freedman, PhD, Joseph Boni, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2543.
https://doi.org/10.1182/blood.V130.Suppl_1.2543.2543
Published: 2017
Journal Articles

A Population Pharmacokinetic and Pharmacodynamic Evaluation of Pralatrexate in Patients with Hematologic Malignancies.

Diane R. Mould, PhD, Kevin Sweeney, Stephen Duffull, Ellen Neylon, RN, Owen A. O’Connor, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1370.
https://doi.org/10.1182/blood.V110.11.1370.1370
Published: 2007
Journal Articles

Population Pharmacokinetics of Alemtuzumab in Patients with Hematologic Malignancies.

Peter L. Bonate, Michael Keating, Steve Weitman, Peter Hillmen, Diane R. Mould
Journal: Blood
Blood (2005) 106 (11): 2961.
https://doi.org/10.1182/blood.V106.11.2961.2961
Published: 2005